ELRIG Drug Discovery

XenoGesis exhibiting at ELRIG Drug Discovery 2019

XenoGesis will be exhibiting at ELRIG Drug Discovery 2019 in Liverpool on the 5-6 November.

ElRIG Drug Discovery 2019, a two-day exhibition and conference, will focus on ‘A look back to the future’ and will include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future.

Rachel Hemsley, Global Head of Business Development, and Wendy Tomlinson, Director of Cell-Based Assay Development will be attending and can be found on booth G8.

XenoGesis will also be presenting their poster: The use of an in vitro media loss assay to assess hepatic uptake in vivo.


If you’d like to get in touch with one of our scientists, please click here!